1.55
0.00 (0.00%)
| Penutupan Terdahulu | 1.55 |
| Buka | 1.48 |
| Jumlah Dagangan | 196,701 |
| Purata Dagangan (3B) | 571,098 |
| Modal Pasaran | 54,582,244 |
| Harga / Buku (P/B) | 13.65 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 31 Mar 2026 |
| EPS Cair (TTM) | -0.990 |
| Nisbah Semasa (MRQ) | 1.16 |
| Aliran Tunai Operasi (OCF TTM) | -10.08 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -12.28 M |
| Pulangan Atas Aset (ROA TTM) | -263.81% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | OS Therapies Incorporated | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.5 |
| Purata | -1.25 |
|
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 33.38% |
| % Dimiliki oleh Institusi | 1.38% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Stratos Wealth Advisors, Llc | 31 Dec 2025 | 13,817 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |